|
WO2020230813A1
|
|
Agent for preventing, ameliorating, or treating periodontal disease
|
|
EP3804709A1
|
|
Autophagy activating agent
|
|
US2020147021A1
|
|
Blood flow improver
|
|
WO2018174266A1
|
|
Novel pyridone carboxylic acid derivative or salt thereof
|
|
US2019276407A1
|
|
Pyridonecarboxylic acid derivative or salt thereof
|
|
SG11201710015UA
|
|
Antihypertensive agent
|
|
JP2017114810A
|
|
Novel pyrrole derivative
|
|
US2017360731A1
|
|
Immunomodulator
|
|
JP2013010753A
|
|
Sugar-coated preparation and production method for the same
|
|
JP2012051945A
|
|
Capsule, method for manufacturing the same, and capsule wall
|
|
WO2012014699A1
|
|
Therapeutic agent for neurological diseases
|
|
JP2011050377A
|
|
New hla-drb1 gene and use thereof
|
|
JP2010162020A
|
|
New hla-drb1 gene, and use thereof
|
|
JP2011042622A
|
|
Fermentation product of vegetable belonging to genus foeniculum
|
|
WO2009101967A1
|
|
Phosphatidylserine complex and method for stabilization of phosphatidylserine
|
|
WO2009063987A1
|
|
Novel use of processed ginseng
|
|
JP2009132696A
|
|
Hla-b54 new allele
|
|
US2010285147A1
|
|
Crude drug extract-blended liquid medicine
|
|
JP2009050258A
|
|
New allele of hla-a2 (human leukocyte antigen-a2)
|
|
JP2009080096A
|
|
Hla antibody analyzer, its method, and program
|
